Stage IVB Lung Cancer AJCC v8

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12267Brigatinib0Recruiting1
DB12565Abexinostat1Recruiting1
DB00112Bevacizumab1Not Yet Recruiting1
DB12267Brigatinib1Not Yet Recruiting1
DB09037Pembrolizumab1Not Yet Recruiting1
DB09037Pembrolizumab1Recruiting1
DB09143Sonidegib1Not Yet Recruiting1
DB11714Durvalumab1 / 2Recruiting1
DB14145Nepidermin1 / 2Recruiting1
DB11793Niraparib1 / 2Not Yet Recruiting1
DB06132Nivolumab1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB09330Osimertinib1 / 2Recruiting1
DB01269Panitumumab1 / 2Suspended1
DB09037Pembrolizumab1 / 2Recruiting2
DB11689Selumetinib1 / 2Recruiting1
DB15232Telaglenastat1 / 2Recruiting1
DB00853Temozolomide1 / 2Not Yet Recruiting1
DB08911Trametinib1 / 2Recruiting1
DB11771Tremelimumab1 / 2Recruiting1
DB11363Alectinib2Recruiting1
DB11945Avelumab2Not Yet Recruiting1
DB12267Brigatinib2Recruiting1
DB00958Carboplatin2Recruiting1
DB00958Carboplatin2Suspended1
DB09063Ceritinib2Recruiting1
DB14547Chloride ion2Recruiting1
DB00515Cisplatin2Recruiting1
DB08865Crizotinib2Recruiting1
DB01248Docetaxel2Recruiting1
DB14860Ensartinib2Recruiting1
DB00441Gemcitabine2Recruiting2
DB06599Lexatumumab2Not Yet Recruiting1
DB06599Lexatumumab2Recruiting1
DB12130Lorlatinib2Recruiting1
DB09035Nivolumab2Recruiting1
DB09330Osimertinib2Recruiting1
DB01229Paclitaxel2Suspended1
DB09037Pembrolizumab2Not Yet Recruiting1
DB09037Pembrolizumab2Recruiting1
DB00642Pemetrexed2Recruiting2
DB11759Pevonedistat2Suspended1
DB12257Platinum2Recruiting1
DB05578Ramucirumab2Not Yet Recruiting1
DB05578Ramucirumab2Recruiting1
DB12332Rucaparib2Recruiting1
DB11760Talazoparib2Not Yet Recruiting1
DB00135Tyrosine2Recruiting1
DB13104X-3962Recruiting1
DB06645Anamorelin2 / 3Recruiting1
DB00112Bevacizumab3Not Yet Recruiting1
DB09330Osimertinib3Not Yet Recruiting1